SPERO THERAPEUTICS INC. - COMMON STOCK

Spero Therapeutics Enters Into a Non-Dilutive Revenue Interest Financing Agreement With HealthCare Royalty Partners® for Up to $125 Million

30 9月 2021 07:00:01 条件 Nasdaq GlobeNewswire

Spero Therapeutics to Present Data at IDWeek 2021

16 9月 2021 07:05:00 条件 Nasdaq GlobeNewswire

Spero Therapeutics to Present at Three Upcoming Investor Conferences

07 9月 2021 07:05:00 条件 Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

31 8月 2021 15:25:43 条件 Nasdaq GlobeNewswire

Spero Therapeutics Announces Second Quarter 2021 Operating Results and Provides Business Update

05 8月 2021 15:01:01 条件 Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

30 7月 2021 15:33:29 条件 Nasdaq GlobeNewswire

Spero Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021

29 7月 2021 15:01:00 条件 Nasdaq GlobeNewswire

Spero Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference

07 7月 2021 15:01:00 条件 Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 7月 2021 15:01:00 条件 Nasdaq GlobeNewswire

Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206

30 6月 2021 17:46:29 条件 Nasdaq GlobeNewswire

Spero Therapeutics Announces the Initiation of Bronchoalveolar Lavage and Renal Impairment Clinical Trials of SPR206

15 6月 2021 15:01:00 条件 Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 5月 2021 16:35:49 条件 Nasdaq GlobeNewswire

Spero Therapeutics Awarded up to $23 Million by the National Institute of Allergy and Infectious Diseases to Support the Development of SPR206

17 5月 2021 15:01:00 条件 Nasdaq GlobeNewswire

Spero Therapeutics to Participate at the Berenberg Conference USA

13 5月 2021 07:00:01 条件 Nasdaq GlobeNewswire

Spero Therapeutics Announces First Quarter 2021 Operating Results and Provides Business Update

06 5月 2021 15:01:01 条件 Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

30 4月 2021 15:26:03 条件 Nasdaq GlobeNewswire

Spero Therapeutics to Provide Business Update and Report First Quarter 2021 Financial Results on Thursday, May 6, 2021

29 4月 2021 15:01:00 条件 Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

31 3月 2021 15:31:39 条件 Nasdaq GlobeNewswire

Spero Therapeutics Announces Fourth Quarter and Full-Year 2020 Operating Results and Provides Business Update

11 3月 2021 15:07:00 条件 Nasdaq GlobeNewswire

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full-Year 2020 Financial Results on Thursday, March 11, 2021

03 3月 2021 07:30:00 条件 Nasdaq GlobeNewswire